MannKind Corp. (MNKD)
4.075
-0.08
(-1.81%)
USD |
NASDAQ |
Aug 24, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
MannKind Shareholders Equity (Quarterly) : -67.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.20M |
| March 31, 2026 | -59.20M |
| December 31, 2025 | -51.02M |
| September 30, 2025 | -44.55M |
| June 30, 2025 | -55.04M |
| March 31, 2025 | -58.62M |
| December 31, 2024 | -78.82M |
| September 30, 2024 | -209.93M |
| June 30, 2024 | -225.78M |
| March 31, 2024 | -229.97M |
| December 31, 2023 | -246.17M |
| September 30, 2023 | -251.78M |
| June 30, 2023 | -260.49M |
| March 31, 2023 | -255.40M |
| December 31, 2022 | -250.54M |
| September 30, 2022 | -237.68M |
| June 30, 2022 | -247.06M |
| March 31, 2022 | -232.06M |
| December 31, 2021 | -209.35M |
| September 30, 2021 | -184.69M |
| June 30, 2021 | -183.55M |
| March 31, 2021 | -173.62M |
| December 31, 2020 | -180.42M |
| September 30, 2020 | -186.42M |
| June 30, 2020 | -179.71M |
| Date | Value |
|---|---|
| March 31, 2020 | -198.05M |
| December 31, 2019 | -190.53M |
| September 30, 2019 | -184.71M |
| June 30, 2019 | -196.00M |
| March 31, 2019 | -188.00M |
| December 31, 2018 | -175.08M |
| September 30, 2018 | -205.44M |
| June 30, 2018 | -206.62M |
| March 31, 2018 | -223.21M |
| December 31, 2017 | -214.73M |
| September 30, 2017 | -251.02M |
| June 30, 2017 | -221.24M |
| March 31, 2017 | -198.72M |
| December 31, 2016 | -183.59M |
| September 30, 2016 | -238.69M |
| June 30, 2016 | -366.58M |
| March 31, 2016 | -373.46M |
| December 31, 2015 | -350.33M |
| September 30, 2015 | -124.57M |
| June 30, 2015 | -115.48M |
| March 31, 2015 | -97.03M |
| December 31, 2014 | -73.77M |
| September 30, 2014 | -40.68M |
| June 30, 2014 | -46.38M |
| March 31, 2014 | 17.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| United Therapeutics Corp. | 6.400B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Gilead Sciences, Inc. | 11.83B |
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Ocugen, Inc. | -16.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 732.30M |
| Total Liabilities (Quarterly) | 799.50M |
| Debt to Equity Ratio | -6.494 |
| Current Ratio | 1.720 |
| Net Debt Paydown Yield | -4.28% |